Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
PsyBio Therapeutics Corp
V.PSYB.H
Alternate Symbol(s):
PSYBF
Healthcare
Biotechnology
PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged...
in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:PSYB.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(298)
•••
PuerSimia
X
View Profile
View Bullboard History
Comment by
PuerSimia
on Apr 09, 2021 5:16pm
RE:Dr. Michael Spigarelli
I was surprised to see that the Dr. Spigarelli NR did zero to move the stock. I wasn't expecting much, but the stock actually closed down that day. I see the stock closed up today, after
...more
(298)
•••
PuerSimia
X
View Profile
View Bullboard History
Post by
PuerSimia
on Apr 07, 2021 2:24pm
.33 like I figured
Too cheap too resist.
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Post by
Bookworm28
on Apr 05, 2021 7:23pm
Dr. Michael Spigarelli
Today's PR seemed like a good one, with Dr. Spigarelli joining the team. Not much reaction to it. Where's the market maker for psyb? This should have sent the stock up .05-.10 a share, no?
(298)
•••
PuerSimia
X
View Profile
View Bullboard History
Comment by
PuerSimia
on Mar 31, 2021 11:02pm
RE:RE:RE:RE:RE:RE:RE:Time to Nibble at More Shares?
Sure did. Not too much for sale, but that's OK.
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 30, 2021 9:31pm
RE:RE:RE:RE:RE:RE:Time to Nibble at More Shares?
Good call PuerSimia. Did you get some at .33? I picked up some BLDP, as you recommended. Popped in and out for some easy money today. Thanks.
(298)
•••
PuerSimia
X
View Profile
View Bullboard History
Comment by
PuerSimia
on Mar 24, 2021 10:44pm
RE:RE:RE:RE:RE:Time to Nibble at More Shares?
I think we might test .33 again in the next couple of days.
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 24, 2021 5:07pm
RE:RE:RE:RE:Time to Nibble at More Shares?
What do you guys figure? We at the bottom yet?
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 24, 2021 3:29pm
RE:RE:RE:Time to Nibble at More Shares?
Hmmm, I liked the share price better before they started telling their story. .365 today is not doing much for my confidence.
(0)
•••
ValueValue123
X
View Profile
View Bullboard History
Comment by
ValueValue123
on Mar 24, 2021 12:54am
RE:RE:Time to Nibble at More Shares?
So far PSYB's operaitonal press release have been substantive compare to what other are putting out. Agreed? Psilocybin w. Albany Molecular (March 3):https://financialpost.com/globe
...more
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 23, 2021 10:06pm
RE:Time to Nibble at More Shares?
You're not the only one scratching their head PuerSimia. I agree with ValueValue123's comment about the stock being totally undervalued compared to their peers. Looking at the trading data, my
...more
(0)
•••
ValueValue123
X
View Profile
View Bullboard History
Comment by
ValueValue123
on Mar 23, 2021 3:22pm
RE:Time to Nibble at More Shares?
Based on my review of PSYB and its peers (FTRP, CYBN, NUMI, etc.), this seems tremendosuly undervlaued (~C$40m comapred to C$200m+). The RTO financing was done at C$0.35 per share with a raise of C$14
...more
(298)
•••
PuerSimia
X
View Profile
View Bullboard History
Post by
PuerSimia
on Mar 23, 2021 2:08pm
Time to Nibble at More Shares?
Bookworm, we are at .38 cdn today. I bought a few more shares, but starting to have second thoughts about it being a good idea. Today's news release should have supported the price, not pushed it
...more
(21)
•••
lonade
X
View Profile
View Bullboard History
Comment by
lonade
on Mar 19, 2021 2:59am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Best Kept Secret on the TSX Venture
i do not consider it mm doing a bad job... i invest a lot in newly listed companies on the venture and i always see a stagnant period first where shares get transferred and allocated. a lot of shares
...more
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 18, 2021 5:12pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Best Kept Secret on the TSX Venture
P.S. Thanks for the link. I thought the CEO's comments, "CEO Evan Levine said the biotechnology company has received a “tremendous amount of investment interest from top tier health care
...more
(70)
•••
Bookworm28
X
View Profile
View Bullboard History
Comment by
Bookworm28
on Mar 18, 2021 4:40pm
RE:RE:RE:RE:RE:RE:RE:RE:Best Kept Secret on the TSX Venture
I had a look at https://ceo.ca/psyb . Seems like everyone is of a similar mind. Not too many people know about the stock, and the market maker is doing a pretty "crappy" job managing
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada